Ovarian luteal activity and reproductive performance of heifers with norgestomet prototype implants

• Published in: Theriogenology Vol. 37; no. 3; pp. 619 - 629
• Main Authors: Hill, G.M., Lucas, D.M., Richardson, K.L., Baker, J.F., Kiser, T.E.
• Format: Journal Article
• Language: English
• Published: United States Elsevier Inc 01.03.1992
• Subjects: BOVIN DE BOUCHERIE; CORPS JAUNE; CUERPO LUTEO; GAIN DE POIDS; GANADO DE CARNE; GANANCIA DE PESO; GENISSE; heifer; implant; METHODE D'APPLICATION; METODOS DE APLICACION; Norgestomet; NOVILLA; OXITETRACICLINA; OXYTETRACYCLINE; PASTOREO; PATURAGE; PROGESTAGENE; PROGESTAGENOS; progesterone; RACE; RAZAS; VACA; VACHE; implant; progesterone; heifer; Norgestomet
• ISSN: 0093-691X; 1879-3231
• DOI: 10.1016/0093-691X(92)90142-E

A 122-day trial was conducted with grazing beef heifers (N=120; 14 to 17 months of age) to determine the effects of a silastic Norgestomet prototype implant on heifer weight gain and on the suppression of ovarian luteal activity. The retention rate of the Norgestomet implants and of silastic placebo implants, which were either left untreated, or were topically treated with oxytetracycline, was determined. Medication of the placebo implants with oxytetracycline increased (P < 0.01) implant retention rate at both Day 56 and Day 122. Heifers with Norgestomet implants had higher body weight gains during the last 66 days (P < 0.05), and during the entire 122-day trial (P < 0.07) than heifers with placebo implants. Serum progesterone concentrations on Day 111 or Day 112 indicated a decrease (P < 0.01) in percentage of heifers with ovarian luteal activity on the Norgestomet treatment compared with heifers receiving placebos (23.8% vs 87.7%, respectively). The Norgestomet implant has the potential for suppressing ovarian luteal activity while improving weight gain in beef heifers.